QUEBEC CITY, Feb. 28 /CNW/ - Medicago Inc. ("Medicago" or "the Company"),
(TSX-V: MDG), a developer of innovative protein manufacturing solutions using
plants, today announced that it had retained The Equicom Group Inc.
("Equicom") to provide the Company with strategic investor relations and
financial communications services.
Equicom provides strategic communications services to approximately 100
public companies across a diverse range of industries. Under the terms of the
agreement, Medicago will pay Equicom a monthly retainer fee of $5,000 for
professional services. The initial contract term is 12 months. Neither Equicom
nor any of its principals has an ownership interest, directly or indirectly,
in Medicago or its securities, and the Company has not granted Equicom or its
principals any right to acquire such an interest. Equicom is an employee-owned
firm whose principals include Barry Hildred, President and Jason Hogan,
Executive Vice President.
About Medicago
Medicago is a biotechnology company focused on the development,
production and commercialization of protein-based biopharmaceuticals using a
proprietary manufacturing system developed from its expertise in the genetic
engineering of plants. Medicago's Proficia technology offers speed,
flexibility and cost advantages that can greatly improve the accessibility of
today's emerging biopharmaceuticals for both partners and patients. The
Company has established collaboration agreements notably with Acambis PLC
(NASDAQ: ACAM, www.acambis.com) for the development of several products and is
also developing its own proprietary pipeline.
About Equicom
Headquartered in Toronto, with offices in Montreal and Calgary, The
Equicom Group is Canada's leading Investor Relations consulting firm. With
proven expertise in developing and executing highly effective strategic
communications programs, and an extensive network of investment community
contacts, Equicom specializes in helping clients achieve their capital markets
objectives. Equicom offers a comprehensive suite of services including:
investor relations, media relations, annual report production, multimedia and
web design, web casting, live event management and corporate branding. For
further information, please visit www.equicomgroup.com.
The TSX Venture Exchange Inc. has not reviewed and does not accept
responsibility for the adequacy or accuracy of this release.
%SEDAR: 00023641EF
For further information: Andy Sheldon and Pierre Labbé, Chief Executive
Officer and Chief Financial Officer, Tel.: (418) 658-9393, Email:
labbep@medicago.com; Eric Bouchard, Investor Relations, The Equicom Group,
Tel: (514) 844-7997, Email: ebouchard@equicomgroup.com
